Human Aortic Smcs
Human Aortic Smcs - Related Videos
12:17
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
0 Views •
Cited by 4 •
2017
Full-root aortic valve replacement by stentless aortic xenograft is a viable option in patients with small aortic roots. We describe, a technique for the full-root implantation of stentless aortic xenografts, with emphasis on the management of the proximal suture line and coronary anastomoses, and discuss its limitations and alternative options.
06:43
Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
0 Views •
Cited by 51 •
2013
We describe procedures to quantify and characterize atherosclerotic lesions in mouse models using precision sectioning of the aortic sinus and ascending aorta combined with histochemical and immunohistochemical analysis.
09:12
Aortic Ring Assay
0 Views •
Cited by 42 •
2009
Angiogenesis, the sprouting of blood vessels from pre-existing vasculature, is associated with both natural and pathological processes. Here we demonstrate an aortic ring assay that allows angiogenic potentiators and inhibitors to be directly added to aortic rings in culture. Sprouting and neovessel outgrowth can be determined by inspecting the aortic rings over a period of 6-12 days.
08:51
A New Murine Model of Endovascular Aortic Aneurysm Repair
0 Views •
Cited by 3 •
2013
Histological and biochemical modifications after aneurysm endograft exclusion are still unclear. We describe a new model of endograft implantation on a murine aneurysm. Through thrombus analysis with and without persistant circulating blood stream interface, and new endovascular biomaterials evaluation, this model will help to better understand endovascular aneurysm exclusion pathobiology.
08:25
Transverse Aortic Constriction in Mice
0 Views •
Cited by 263 •
2010
Transverse aortic constriction (TAC) in the mouse is a commonly used experimental model to study mechanisms underlying cardiac hypertrophy and heart failure development. Here, we describe procedures to constrict the aorta to create a reproducible degree of cardiac hypertrophy in mice.
FAQs
Human aortic SMCs can shift among contractile, synthetic, and proliferative states in response to their environment. This switching changes how they regulate vessel structure, respond to biochemical and mechanical cues, and participate in vascular remodeling. Bioengineers use these state changes to evaluate whether a scaffold or culture condition supports stable vascular function or promotes disease-associated remodeling.
Calcium-dependent actin-myosin contraction provides a functional readout of how human aortic SMCs respond to vascular signals. It links biochemical stimulation to cell-generated force and vessel regulation. In engineered systems, observing contractile behavior helps researchers assess whether cells retain appropriate vascular function and whether biomaterials or experimental conditions influence the contractile response.
Matrix composition and mechanical cues can influence human aortic SMC state, contractile behavior, and remodeling responses. These variables are therefore central to vascular bioengineering, where the surrounding material and physical environment must be evaluated alongside cellular behavior. Comparing conditions helps determine how closely an engineered construct reproduces relevant aspects of the aortic vascular environment.
Inflammatory factors provide a way to examine how human aortic SMCs respond to disease-associated biochemical conditions. Their effects can be studied together with matrix and mechanical signals to investigate changes linked to vascular remodeling. This approach helps connect cellular responses with aortic disease mechanisms and supports evaluation of whether engineered models reproduce relevant biological challenges.
In vascular graft and tissue-engineering studies, human aortic SMCs provide a cellular component for examining vascular function and construct performance. Researchers can assess how the cells respond to the surrounding biomaterial and experimental environment, including matrix and mechanical cues. These observations help guide development of engineered blood vessels intended to model or support vascular structure and function.
Responses of human aortic SMCs to matrix composition, mechanical signals, and inflammatory factors can indicate how a biomaterial influences vascular cell behavior. Researchers can use these responses to compare materials and culture conditions for effects on contractile function or remodeling-related states. The resulting data support decisions about whether a material is suitable for vascular graft or tissue-engineering applications.
Human aortic SMCs are useful when an in vitro model must represent cellular processes involved in aortic vascular remodeling. Their ability to respond to biochemical and mechanical cues allows researchers to examine disease-related changes under controlled conditions. Such models can support investigation of mechanisms and provide a platform for evaluating how drugs influence vascular cell behavior.
Drug evaluation can focus on how treatments alter human aortic SMC contraction, phenotype, or responses to matrix, mechanical, and inflammatory conditions. These measurements connect treatment exposure with cellular behaviors relevant to vascular function and remodeling. In bioengineering research, the cells therefore contribute to in vitro platforms for comparing drug effects within controlled models of aortic disease.